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Introduction
NK cells are prototypic innate lymphocytes and have originally 
been identified by their ability to spontaneously kill transformed 
and infected cells (1–3). They recognize their targets by balancing 
signals of activating and inhibitory receptors, resulting in miss-
ing-self recognition upon loss of inhibitory ligands, mostly MHC 
class I molecules, and altered-self recognition upon gain of acti-
vating ligands on the surface of encountered cells (4–6). The abili-
ty of NK cells to detect too few inhibitory ligands or too many acti-
vating ligands in reference to unaltered host tissue is thought to be 
acquired by NK cells in a continuous process called “education” or 
“licensing” via the interaction of inhibitory NK cell receptors and 
MHC class I molecules (7–9). Whether NK cell education is medi-
ated “in cis” (on the NK cell itself) or “in trans” (by neighboring 
cells) or both is still a matter of debate (10–13), however, the hema-
topoietic compartment seems to be sufficient in both mice and 
humans for NK cell education (11, 14). Along these lines, the recip-
ient HLA haplotype was not found to significantly abolish donor 
NK cell alloreactivity via education during the first 3 months after 
BM transplantation (15). Within the hematopoietic compartment, 
multiple cell populations probably contribute to NK cell educa-
tion, including the partial contribution of T cells that was previ-
ously identified in the mouse (12). The process of education safe-
guards NK cell cytotoxicity by either “arming” cells that express, 
in parallel to activating NK cell receptors, inhibitory receptors that 
are sufficiently engaged by unaltered host cells, or by “disarming” 
through continuous engagement of activating receptors without 
inhibitory signals (16, 17). While most activating NK cell receptors 
are nearly uniformly expressed on all mature NK cells, inhibitory 
receptors are expressed on subsets, whose contribution to the NK 
cell repertoire of an individual is guided by genetic and environ-
mental factors, e.g., the genomic repertoire of killer Ig-like recep-
tors (KIRs) and persistent CMV (HCMV) infection in humans (18). 
This composition of the NK cell repertoire becomes particularly 
important during primary infection with pathogens like herpesvi-
ruses, which clinically identify individuals with primary immuno-
deficiencies that impair NK cell functions (19).
One of these is the infection with the human oncogenic γ-her-
pesvirus EBV. EBV persistently infects more than 90% of the 
human adult population (20). While primary infection is usually 
asymptomatic in children, adolescents more frequently suffer 
from infectious mononucleosis (IM) during their first encounter 
with EBV (21, 22). While EBV is associated with B cell and epithe-
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increased susceptibility to IM in adolescents. Thus, EBV infection 
seems to be sensitive to the balance between non-KIR–educated 
NK cells, which are either KIR– or whose KIRs have not encoun-
tered cognate MHC class I molecules, and KIR-educated NK cells.
In our study, we investigated NK cell repertoire generation 
and NK cell education and their influence on the control of EBV 
infection in mice with reconstituted human immune system com-
ponents (huNSG mice). For this purpose, we either reconstituted 
human NK cell compartments from hematopoietic progenitor 
cells (HPCs) that homozygously carry MHC class I molecules for 
distinct KIRs individually or in mixed chimeras. We found that the 
distribution of KIRs on the reconstituted human NK cells is donor 
autonomous and independent of environmental MHC class I 
molecules, while education, mediated by the hematopoietic com-
partment in this setting, is compromised as soon as a subset of 
immune cells does not carry the cognate MHC class I molecules. 
Thus, abrogation of the educational process seems to result from 
activating receptor engagement with co-reconstituting hemato-
poietic cells in the absence of inhibitory signaling. This results in 
higher frequencies of noneducated NK cells in the mixed reconsti-
tutions and an improved immune control of EBV infection. There-
fore, our findings are most consistent with a disarming model of 
KIR-mediated education, resulting in NK cell compartments, 
which, because of the inflammatory environment of EBV infec-
tion, nevertheless efficiently control this human tumor virus.
Results
An in vivo model with parallel reconstitution of 2 donors’ immune 
compartments in NSG mice. Double-unit umbilical cord blood 
transplantation is successfully being used to improve engraftment 
and decrease mortality in patients (29, 30). During the engraft-
ment process, mostly 1 donor prevails, which leads to single-unit 
engraftment (31, 32). Human NK cell education, however, has 
been shown to be driven by the hematopoietic compartment (14). 
Therefore, little data are available on how the absence of cognate 
human MHC class I molecules, namely cognate HLA class I mol-
ecules, on hematopoietic cells influences the education and KIR 
repertoire of human NK cells in trans. In order to study the effect 
of cognate versus noncognate HLA on NK cell development, we 
reconstituted NOD-SCIDγc–/– (NSG) mice with HLA-typed human 
HPCs isolated from fetal livers (huNSG mice). Human fetal liv-
er (HFL) donors were chosen to be homozygous for the HLA-C 
and -B allotypes (HLA-C1, -C2, and -Bw4), which are recognized 
by KIR2DL and KIR3DL molecules, respectively. Furthermore, 
donors were disparate for HLA-A2 expression, which allowed us 
to track the progeny of specific donors in mixed reconstitution 
lial malignancies through its viral oncogenes that are expressed 
during latent infection, lytic replication that produces infectious 
virions seems to be poorly controlled during IM and causes the 
characteristic immune pathogenic CD8+ T cell lymphocytosis of 
this disease (23). NK cells were reported to expand during IM (21, 
24, 25) and seem to particularly restrict lytic EBV infection that is 
deregulated during IM (25, 26). Interestingly, and in contrast to the 
prototypic terminally differentiated NK cell–expanding pathogen 
HCMV, EBV seems to drive the proliferation of early differentiat-
ed non-KIR–educated NK cells (25, 27). These NK cells have been 
reported to recognize B cells that lytically replicate EBV via rec-
ognition by the activating NK cell receptors NKG2D and DNAM-1 
(28), and the respective ligands for these receptors seem to be 
upregulated during transition from latent to lytic EBV infection 
(25, 28). Loss of NK cells leads to elevated viral loads of WT, but 
not lytic replication–incompetent, EBV in vivo (26). This in turn 
causes hallmarks of IM, including enhanced CD8+ T cell expan-
sion and lymphadenopathy, as well as weight loss and EBV- 
associated tumorigenesis in EBV-infected experimental animals 
(26). Moreover, the protective early differentiated NK cell subset 
decreases in frequency within the NK cell repertoire of humans 
during the first decade of life (25) and therefore could explain the 
Figure 1. Mixed reconstitution of human immune system compartments 
from HLA-mismatched HPCs in NSG mice. (A) Representative experimen-
tal overview. Three types of experimental groups were used: two groups 
reconstituted homozygously for HLA-C and -B allotypes (HLA-C1, -C2, and 
-Bw4), while disparate for HLA-A2, and the third group with a mix of both. 
(B) Reconstitution of human immune cell compartments in the 3 exper-
imental groups as a percentage of human CD45+ lymphocytes. (C) Ratio 
of HLA-C1 donor versus HLA-C2 donor frequencies as distinguished by 
HLA-A2 expression in immune cell compartments of mixed reconstituted 
huNSG mice. Data were pooled from at least 4 independent experiments.  
n = 34–49. Bars represent the mean in the respective graphs.
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nate HLA presence or absence in trans on NK cell education and 
KIR repertoire development.
Development of the KIR repertoire on NK cells is not influenced by 
the HLA haplotype in trans. Next, we analyzed the KIR repertoire 
of NK cells in liver and spleen of reconstituted huNSG mice and 
compared it with the KIR repertoire as present in the fetal liver 
of the original donor (Figure 2, Supplemental Figure 1 for gating, 
Supplemental Figure 2, and data not shown; supplemental mate-
rial available online with this article; doi:10.1172/JCI86923DS1). 
In order to detect differences in mixed reconstituted huNSG mice, 
NK cells from these mice were separately evaluated according to 
donor origin. The overall diversity of the KIR repertoire was com-
parable to that of all groups as well as to that in the donor HFLs, 
and no preferential expansion of KIR subsets could be seen (Fig-
ure 2, A–F). When relating the KIR frequencies of reconstituted 
experiments (Figure 1A). Three types of experimental mouse 
groups were reconstituted in this study. Two single-donor hema-
topoietic cell–reconstituted groups (referred to hereafter as single 
reconstituted) homozygous for either HLA-C1 (recognized by 
KIR2DL2/3) or HLA-C2 (recognized by KIR2DL1) and HLA-Bw4 
(recognized by KIR3DL1) were set up in parallel to a third group 
that was reconstituted with a mix of hematopoietic cells from 
both donors (referred to hereafter as mixed reconstituted). The 
results of reconstitution of human CD45+ leukocytes in general, 
as well as the frequencies of reconstituted T cells, B cells, and NK 
cells, were comparable to those of previous studies conducted in 
our laboratory (Figure 1B) (33, 34). Notably, mixed reconstituted 
huNSG mice developed cells from both donors side by side in all 
the reconstituted human immune system compartments (Figure 
1C). Thus, we established a model to study the influence of cog-
Figure 2. HLA haplotype in trans does not influence the KIR repertoire in steady state. HuNSG mice were single reconstituted with donors homozy-
gous for HLA-C and -B allotypes (HLA-C1, -C2 , and -Bw4) (single) or reconstituted with 2 donors disparate for allotype and HLA-A2 expression (mixed). 
Gray pie charts depict the frequencies of KIR+ and KIR– NK cells, and colored pie charts represent the indicated KIR+ NK cell subsets. (A–F) Represen-
tation of KIR-expressing NK cell subsets as a percentages of total KIR+ NK cells in liver of huNSG mice (A–D) or of HFL donors (E and F). KIR subsets 
of liver NK cells from huNSG mice reconstituted with single donors homozygous for HLA-C1 (A) or -C2 (B). (C and D) KIR subsets of liver NK cells from 
mixed reconstituted huNSG mice, with NK cells derived from HLA-C1 (C) and HLA-C2 (D) donors. (E and F) KIR subsets of NK cells from HLA-C1 (E) or 
-C2 (F) HFLs. n = 3. (G and H) Mean percentage per experiment of single KIR+ liver NK cells as derived from total NK cells of huNSG mice. Frequencies 
of KIR+ NK cells in single reconstituted huNSG mice as compared with those in HFL donors (G) and mixed reconstituted huNSG mice (H). Data were 
pooled data from at least 3 independent experiments. n = 11–14 mice per group. (G and H) Dots represent the mean of the cell population in separate 
experiments (paired 2-tailed Student’s t test).
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(Figure 2H and Supplemental Figure 2). In spleen, a KIR repertoire 
composition similar to that in the liver was observed but could not 
be compared with the splenic NK cell repertoire of the HFL donors 
(data not shown). Hence, it seems that the absence of cognate HLA 
on co-reconstituting hematopoietic cells does not influence the 
development of the KIR repertoire in the steady state.
EBV infection does not force skewing of the KIR repertoire on 
NK cells in huNSG mice. Previous work has established profound 
effects of human CMV infection on the NK cell KIR repertoire and 
mice to their specific HFL donors, a correlation could be detected 
between the two (Figure 2G and Supplemental Figure 2). Name-
ly, HFL donors with, for example, high frequencies of KIR2DL1, 
KIR2DL2/3, or KIR3DL1 single-positive NK cells reconstituted the 
respective NK cell subsets also at higher frequencies. Importantly, 
in mixed reconstituted huNSG mice, the presence of noncognate 
HLA in trans did not significantly change the KIR repertoire (Figure 
2, C and D), and no differences were detectable when comparing 
specific KIR frequencies with those of single reconstituted mice 
Figure 3. Infection with EBV does not lead to skewing of KIR repertoire. HuNSG mice were single reconstituted with donors homozygous for HLA-C and -B 
allotypes (HLA-C1, -C2, and -Bw4) or reconstituted with 2 donors disparate for allotype and HLA-A2 expression (mixed). Gray pie charts depict the frequen-
cies of KIR+ and KIR– NK cells, and colored pie charts represent the indicated KIR+ NK cell subsets. (A–D) Subsets of KIR-expressing NK cells as a percentages 
of total KIR+ NK cells in spleens of EBV-infected huNSG mice. (E–P) Frequency of single KIR + NK cells in spleens of huNSG mice at endpoint. Comparison of 
PBS controls with EBV-infected animals for frequency of KIR2DL1+, KIR2DL2/3+, or KIR3DL1+ NK cells in homozygous reconstituted mice with HLA-C1 donor 
(E–G), mixed reconstituted mice with cells derived from HLA-C1 (H–J) or -C2 (K–M) donors, and homozygous reconstituted mice with cells from HLA-C2 
donors (M–P). Data are pooled from at least 3 independent experiments. n = 8–15 mice per group. Bars represent the mean (unpaired Student’s t test).
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ed NK cells from healthy volunteers (36, 37). Furthermore, acute 
infection with EBV did not influence this process. In contrast, how-
ever, the additional presence of noncognate HLA in trans in mixed 
reconstituted huNSG mice prevented NK cells from being educat-
ed (Figures 4, A–C). Interestingly, education was lost regardless of 
the donor ratio in the mixed reconstituted animals and was even 
observed when the cognate HLA– leukocyte reconstitution only 
amounted to 5% of the total human immune components (Supple-
mental Figure 4, A–C). This argues against a dose effect of cognate 
HLA and for the disarming model in KIR-mediated NK cell educa-
tion as an active process, whereby activating receptor engagement 
in the absence of inhibitory signaling renders NK cells hyporespon-
sive. When looking at education in the context of NKG2A and its 
ubiquitously present educating HLA-E ligand, both mixed and sin-
gle reconstituted huNSG mice showed equal education, consistent 
with invariant HLA-E expression by all HFL donors (Figure 4D). 
Additionally, we could also show that education was detectable in 
the livers of huNSG mice, albeit at decreased overall degranulation 
capacity, consistent with the findings of previous studies (38, 39). 
Therefore,  human NK cell education takes place in huNSG mice, 
independently of EBV infection, is mediated by the hematopoietic 
compartment, and is reliant on the presence of cognate HLA on all 
hematopoietic cells. Furthermore, the abrogation of NK cell educa-
tion in mixed reconstituted animals seems to be dependent on the 
loss of inhibitory signaling in trans.
Noneducated NK cells still display inhibition in response to cognate 
HLA. In addition to analyzing the education of human NK cells in 
expansion of KIR educated NKG2C+ NK cells (18, 35). In an effort 
to examine whether the KIR repertoire could be skewed by anoth-
er herpesvirus, huNSG mice were infected with EBV and moni-
tored for 5 weeks. At the endpoint, the livers and spleens of infect-
ed animals were analyzed for KIR expression in NK cells (Figure 3 
and Supplemental Figure 3). EBV infection did not lead to obvious 
changes in the KIR+ NK cell subset composition in single or mixed 
reconstituted huNSG mice (Figures 3, A–D). Furthermore, when 
comparing frequencies of NK cells that were single positive for 
KIR2DL1, KIR2DL2/3, or KIR3DL1 in EBV-infected animals with 
frequencies in controls, no differences could be detected (Figures 
3, E–P). Stable KIR repertoires were also observed in the livers of 
EBV-infected huNSG mice (Supplemental Figure 3). It therefore 
appears that EBV infection is not able to induce skewing of the KIR 
repertoire in huNSG mice.
Absence of cognate HLA abrogates NK cell education in huNSG 
mice. Whether human NK cells in mouse models reconstituted 
with human immune system components are educated has not 
been addressed so far. To quantify education in huNSG mice, we 
assessed the degranulation of single KIR+ splenic NK cells toward 
a prototypic NK cell target, MHC class I–negative erythroleukemic 
K562 cells, in the context of the educating HLA ligands. The pres-
ence of solely the educating, cognate HLA, as in the case of single 
reconstituted huNSG mice, resulted in education of KIR2DL1+, 
KIR2DL2/3+, and KIR3DL1+ NK cells in HLA-C2, -C1, and -Bw4 
reconstituted animals, respectively (Figures 4, A–C), with function-
al differences similar to those between educated and noneducat-
Figure 4. Loss of NK cell education in the presence of noncognate MHC class I in mixed reconstituted huNSG mice. huNSG mice were single reconstituted 
with donors homozygous for HLA-C and -B allotypes (HLA-C1, -C2, and -Bw4) (Single) or reconstituted with 2 donors disparate for allotype and HLA-A2 
expression (Mixed). Δ%CD107a refers to the difference in degranulation with and without K562 restimulation. The average ± SEM of spontaneous degran-
ulation was 4.04% ± 0.79%. (A–C) Degranulation of single KIR+ NK cells after incubation of K562 cells with splenocytes from huNSG mice reconstituted 
with (A) homozygous HLA-C2 or mixed donors (n = 12–18 mice/group), (B) homozygous HLA-C1 or mixed donors (n = 11–14 mice/group), or (C) homozygous 
HLA-Bw4 or mixed donors (n = 15–20 mice/group), infected (red lines) or not (black lines) with EBV for 5 weeks. According to single reconstituted allotypes, 
eduKIR denotes educated NK cells and non-eduKIR denotes noneducated NK cells gated on cells derived from donors used for single reconstitution in 
both single and mixed reconstituted huNSG mice, respectively. (D) Degranulation of KIR–NKG2A– (non-edu) and KIR–NKG2A+ (edu) NK cells after incubation 
of K562 cells with splenocytes from single or double (Mixed) reconstituted huNSG mice (n = 7–10/group), gated on cells derived from donors used for single 
reconstitution. Data in A–C were pooled from at least 3 independent experiments, data in D are compound data from 2 independent experiments.  
**P < 0.01 and ***P < 0.001, by multiple paired Student’s t tests.
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huNSG mice, we also studied the inherent inhibitory potential 
of specific KIRs. To do so, we tested degranulation toward K562 
cells stably expressing individual HLA-C1, -C2, or -Bw4 molecules 
(Figure 5, C, F, and I). Both educated and noneducated NK cells 
that carry a single KIR specific to the transfected HLA on the tar-
get cell showed reduced levels of degranulation compared with 
unaltered or noncognate HLA-transfected K562 cells (Figure 5, A, 
D, and G; and data not shown). Thus, despite the loss of education 
in NK cells from mixed reconstituted mice (Figure 5, B, E, and H), 
noneducated single KIR+ NK cells still dampened their response 
and exhibited self-inhibition, as previously observed for NK cells 
from healthy volunteers (40). In addition to a reduced education, 
the inhibition of NK cell reactivity by KIR ligand–expressing tar-
gets probably contributes to NK cell tolerance in mixed chimeras.
Mixed reconstituted huNSG mice have superior immune control 
of EBV infection. In order to assess the functional consequence of 
reduced NK cell education, we evaluated immune control of EBV 
infection. It had been previously shown that noneducated NK cells 
are mainly responsible for the innate immune response to mouse 
CMV (MCMV) infection (41). Therefore, we investigated whether 
an increased abundance of noneducated NK cells would improve 
immune control of EBV infection. To follow the disease progres-
sion of EBV-infected huNSG mice, viral loads were assessed on a 
weekly basis in blood and spleen at the experimental endpoints. 
Viral titers were significantly reduced in both the blood and spleen 
of mixed reconstituted animals at the endpoints of the experi-
ments when compared with EBV infection of single-donor recon-
stituted animals (Figures 6, A–D). Furthermore, we also observed 
a reduced CD8+ T cell expansion in response to EBV infection in 
mixed reconstituted huNSG mice (Figure 6E), which indicates a 
lower viral burden and antigen amount. However, the decreased 
expansion to CD8+ T cells in mixed reconstituted animals did not 
result in an altered CD8+ T cell composition (Supplemental Fig-
ure 5, A–H), nor were there differences in the CD8+ T cell effector 
Figure 5. Inhibition by cognate MHC class I ligands is maintained in noneducated NK cells. huNSG mice were single reconstituted with donors homozy-
gous for HLA-C and -B allotypes (HLA-C1, -C2, and -Bw4) (Single) or reconstituted with 2 donors disparate for allotype and HLA-A2 expression (Mixed) and 
incubated with MHC class I–negative target cells (K562) or K562 transfectants expressing HLA-C1, -C2, or -Bw4 MHC class I ligands. Δ%CD107a refers to the 
difference in degranulation with and without K562 restimulation. Average ± SEM of spontaneous degranulation was 3.55% ± 0.73%. (A–C) Degranulation 
of single KIR2DL1+ NK cells after incubation of K562 or K562-C2 cells with splenocytes from huNSG mice reconstituted with HLA-C2 homozygous or mixed 
donors (A) and paired analysis for incubation with K562 cells (B) or K562-C2 transfectants (C). (D–F) Degranulation of single KIR2DL2/3+ NK cells after 
incubation of K562 or K562-C1 cells with splenocytes from huNSG mice reconstituted with HLA-C1 homozygous or mixed donors (D) and paired analysis 
for incubation with K562 cells (E) or K562-C1 transfectants (F). (G–I) Degranulation of single KIR3DL1+ NK cells after incubation of K562 or K562-Bw4 cells 
with splenocytes from huNSG mice reconstituted with HLA-Bw4 homozygous or mixed donors (G) and paired analysis for incubation with K562 cells (H) 
or K562-Bw4 transfectants (I). Data were pooled from at least 2 independent experiments. Bars represent the mean on relevant graphs. n = 7–14 mice per 
group. *P < 0.05, **P < 0.01, and ***P < 0.001, by multiple paired Student’s t tests.
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memory response of the various groups (Supplemental Figure 5I). 
Thus, side-by-side reconstitution of huNSG mice with 2 donors, 
which leads to less-educated NK cells, allows for improved 
immune control against EBV infection.
NK cells mediate improved immune control of EBV infection in 
mixed reconstituted mice. To elucidate a possible role of NK cells in 
the improved immune control of EBV infection, huNSG mice were 
depleted of NK cells prior to infection with EBV (Supplemental 
Figure 6). Interestingly, depletion of NK cells leveled the differ-
ences previously observed in viral loads between mixed reconsti-
tuted and single reconstituted huNSG mice (Figure 7A). Moreover, 
viral titers in both blood and spleen of mixed reconstituted ani-
mals depleted of NK cells were significantly higher compared with 
viral loads in mixed reconstituted animals without depletion of NK 
cells (Figures 7, B and C). Additionally, the loss of NK cell–mediat-
ed protection correlated with an elevated CD8+ T cell expansion in 
NK cell–depleted mixed reconstituted huNSG mice (Figure 7D). 
Finally, in order to investigate the formation of an adaptive NK 
cell compartment upon EBV infection, we assessed surface mark-
ers that had been implicated in NK cell memory formation during 
viral infections (42–44). In accordance with published data, adap-
tive NK cells were phenotypically characterized by a lack of Syk 
expression (Supplemental Figure 7, A and B) as well as lower levels 
of FcεRIγ and NKp46 (Supplemental Figure 7, C and D). Interest-
ingly, only single reconstituted huNSG mice displayed higher fre-
quencies of adaptive NK cells, while mixed reconstituted huNSG 
mice appeared to have more conventional NK cells after EBV 
infection (Supplemental Figure 7B). Furthermore, unlike Liu et 
al. (44), we did not observe increased frequencies of CD2+ cells 
in the adaptive NK cell subset (Supplemental Figure 7E) but did 
find greater frequencies of NK cells carrying educated KIRs (Sup-
plemental Figure 7F). Additionally, in a functional readout using 
plate-bound CD16 to stimulate NK cells, both the conventional 
and adaptive compartments were shown to degranulate slightly 
more upon EBV infection (Supplemental Figure 7G and Supple-
mental Figure 7H). These data indicate that noneducated NK cells 
might play a key role in the improved control of EBV infection in 
mixed reconstituted huNSG mice; however, the phenotypically 
identifiable adaptive NK cell compartment does not appear to cor-
relate with protection.
Discussion
Using mixed HPC reconstitution in NSG mice, we were able to 
assess the influence of cognate HLA absence in trans on KIR rep-
ertoire generation and NK cell education in the reconstituting 
human immune system. We observed that similar repertoires of 
KIR+ NK cells reconstituted in single donor and mixed KIR ligand–
mismatched donor reconstituted NSG mice as well as in the fetal 
liver of the HPC donors used for huNSG generation. In contrast, 
KIR-mediated NK cell education was compromised if even a 
small subset of leukocytes that lacked the respective KIR ligand 
reconstituted in the same NSG mouse in parallel. This indicates 
that KIR-mediated education seems to be even more sensitive 
than Ly49-mediated education, with disarming taking place at a 
KIR ligand–negative frequency below 10% compared with 20% 
for the required Ly49 ligand–negative frequency in the murine 
system (45, 46). Therefore, our findings suggest that such small 
KIR ligand–negative leukocyte populations are able to disarm NK 
cells for decreased missing-self recognition of tumor cells. How-
ever, our data suggest that the availability of a low-affinity binding 
ligand, as is the case for the KIR2DL2/3 ligand HLA-C2 (47), can 
be sufficient to prevent the disarming of NK cells in trans (Figures 
4B and Figure 5, D and E). Hence the mechanism of disarming 
and which leukocyte populations are mainly involved require 
further investigation. Nevertheless, disarming, while disabling 
HLA– tumor cell recognition, improves NK cell–mediated immune 
control of herpesvirus infections, as previously shown for the 
β-herpesvirus MCMV (41) and shown here for the γ-herpesvirus 
EBV (Figures 6 and 7).
In contrast to the lack of imprint of EBV infection in the NK 
cell repertoire, as was observed in this study, HCMV has been 
described to expand terminally differentiated NKG2C+ NK cells 
Figure 6. Improved EBV-specific immune control in mixed 
reconstituted huNSG mice. Viral loads in spleens of huNSG 
mice were read out over time in blood and at the endpoint 
(week 4 or 5). Homozygous single reconstituted huNSG 
mice (Single) were compared with mixed reconstituted mice 
(Mixed). (A and B) Viral loads in blood at weekly time points 
(A) and in spleen (B) of single versus mixed reconstituted 
huNSG mice for a representative experiment (n = 3–9 mice/
group for A. Data represent the mean ± SEM, *P < 0.05 by 
ANOVA with Bonferroni’s correction. (C and D) Fold difference 
in viral load for blood (C) and spleen (D) at the endpoint nor-
malized to the mean of mixed reconstituted group. (E) CD8+/
CD4+ T cell ratio in blood at endpoints in single versus mixed 
reconstituted huNSG mice. Data in C–E were pooled from at 
least 3 independent experiments. n = 15–40. Bars represent 
the mean. *P < 0.05, by Mann-Whitney U or unpaired Stu-
dent’s t test where appropriate.
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molecules on neighboring leukocytes, 
because this family of inhibitory NK 
cell receptors is absent in mice (4), 
and during transplantation with dou-
ble cord blood units, usually 1 donor 
eliminates the other because of allo-
reactive responses by cotransferred 
T cells (31). Therefore, KIR-mediated 
NK cell education cannot be stud-
ied in these settings. Nevertheless, 
understanding KIR-mediated NK 
cell education is of clinical impor-
tance, because it has been shown 
that haploidentical hematopoietic 
cell transplantation, harnessing KIR-
HLA mismatch recognition, provides 
therapeutic benefits in adult acute 
myeloid leukemia (AML) and pedi-
atric acute lymphoblastic leukemia 
(ALL) patients (50–52). It is thought 
that NK cells reconstituting from the 
KIR ligand–mismatched graft medi-
ate a graft-versus-leukemia (GvL) 
effect via missing-self recognition 
of the leukemic blasts. Indeed, it has 
been observed that the reconstitut-
ing NK cells mediate allorecogni-
tion against the recipient’s leukemic 
blasts to an extent similar to that of 
the donor’s mature NK cells and that 
the degree of donor allorecognition of 
recipient cells is the best predictor for 
clinical efficacy (47, 53). These findings suggest that the donor’s 
reconstituting human immune system components are sufficient 
to educate NK cells for KIR ligand–mismatched leukemia recog-
nition, that the allogeneic residual leukemia blasts of the recipient 
are not able to sufficiently disarm the reconstituting NK cells, and 
that also the recipient’s somatic cells are not able to sufficiently 
induce tolerance in the reconstituting donor NK cells. However, 
our data suggest that the GvL effect cannot be further potentiated 
by combining donors with high antileukemic NK cell reactivity, 
because their reconstituting leukocytes might disarm each other 
and result in diminished GvL reactivity, as observed in our study 
in the recognition of the human erythroleukemia cell line K562.
In contrast to possibly diminished GvL activity in mixed 
reconstitutions, the resulting mixed NK cell compartments might 
be superior in preventing EBV-associated lymphomas during 
transplantation. Indeed, most post-transplantation lymphopro-
liferative diseases (PTLDs) are EBV+ (23), and plasma EBV DNA 
copy numbers seem to be a reliable indicator of PTLD occur-
rence and treatment response (54, 55). This might in part reflect 
uncontrolled lytic EBV replication in transplant patients prior to 
PTLD, infecting and transforming reconstituting B cells to result 
in poly- or oligoclonal lymphoproliferations. This lytic replication 
is indeed susceptible to NK cell–mediated immune control, and 
non-KIR educated NK cells have been shown to preferentially tar-
get lytically EBV replicating B cells (25, 26). Furthermore, in the 
that preferentially carry KIRs for self-HLA molecules (18). This 
self-HLA reactive KIR expression might be required to safeguard 
against immunopathology by this expanded, highly cytotoxic NK 
cell population. It has been suggested that this expansion might 
result from the engagement of the CD94/NKG2C receptor by 
HLA-E on HCMV-infected cells in combination with IL-15 and/
or IL-12 produced by infected or bystander myeloid cells (48, 49). 
Indeed, these cytokines might be crucial for the accumulation 
of terminally differentiated NK cells in HCMV carriers, because 
NKG2C-deficient individuals also accumulate NK cell popula-
tions, which are reminiscent in their phenotype and function of 
NKG2C+ NK cells in the absence of this receptor (44). In contrast, 
EBV drives the expansion of preferentially KIR–, early differentiat-
ed NK cell populations, possibly through the direct recognition of 
lytically EBV replicating B cells (25, 26) that do not efficiently pro-
duce the NK cell–differentiating cytokines IL-15 and IL-12. This 
does not seem to result in skewing of the NK cell repertoire. Thus, 
it is possibly the capacity of the target cells of these 2 herpesvirus-
es to produce NK cell–differentiating cytokines, namely IL-12 and 
IL-15, that is responsible for the accumulation of terminally differ-
entiated NK cells during HCMV and early differentiated NK cells 
during EBV infection, resulting, only for HCMV, in alterations of 
the NK cell repertoire.
This study addresses for the first time to our knowledge 
KIR-mediated NK cell education by cognate and noncognate HLA 
Figure 7. NK cells mediate protection in mixed reconstituted huNSG mice. Viral loads of huNSG mice were 
read out over time in blood and at the endpoint (week 4 or 5) in spleens. Homozygous single reconstituted 
huNSG were compared with mixed reconstituted animals, and non–NK cell–depleted (Nondepl) were com-
pared with NK cell–depleted (Depl) mixed reconstituted huNSG mice. (A) Representative experiment for viral 
loads in blood at weekly time points in NK cell–depleted single versus NK cell–depleted mixed reconstituted 
huNSG mice (n = 3–8 mice/group). (B) Viral loads in blood over time in nondepleted (Nondepl) versus NK 
cell–depleted mixed reconstituted huNSG mice. (C) Endpoint viral loads in spleen for nondepleted versus NK 
cell–depleted (Depl) mixed reconstituted huNSG mice. (D) CD8+/CD4+ T cell ratio in blood at the endpoint in 
nondepleted versus NK cell–depleted mixed huNSG mice. Data in B–D were pooled from at least 2 indepen-
dent experiments. n = 8–15 mice per group. Data represent the mean ± SEM or bars represent the mean. *P < 
0.05 and ***P < 0.001, by ANOVA with Bonferroni’s correction, Mann-Whitney U test, or unpaired Student’s 
t test where appropriate. 
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via i.p. injection of purified anti-NKp46 Ab (clone BAB281 provided by 
E. Marcenaro and A. Moretta.) in PBS on 3 consecutive days (total of 
300 μg/mouse). On the following day, animals were infected by inoc-
ulation via i.p. injection of 1 × 105 RIU EBV.
Flow cytometry. All fluorescently labeled Abs were purchased from 
BD Biosciences, Beckman Coulter, BioLegend, Invitrogen (Thermo 
Fisher Scientific), and R&D Systems (Supplemental Table 1). Spleens 
were mechanically disrupted and filtered through a 70-μm cell strainer 
before separation of mononuclear cells on Ficoll-Paque gradients. Liv-
ers were first digested in a buffer containing DNAse and Collagenase 
D (Roche). After being mechanically disrupted, mononuclear cells 
were separated using a Percoll gradient. Lysis of erythrocytes in whole 
blood was done with NH4Cl. For intracellular staining, the Cytofix/
Cytoperm Kit from BD Biosciences was used. Cell suspensions were 
stained with Abs for 30 minutes on ice, washed, and analyzed on a 
FACSCanto or LSR Fortessa cytometer (BD Biosciences). Analysis of 
flow cytometric data was performed with FlowJo software (Tree Star).
K562 cells and their HLA class I transfection. K562 cells were main-
tained in RPMI 1640 medium (Gibco, Thermo Fisher Scientific) sup-
plemented with gentamicin (20 μg/ml) and 10% FCS (Gibco, Ther-
mo Fisher Scientific). Cell cultures were kept in a water-saturated 
atmosphere with 5% CO2 at 37°C. For the generation of HLA-Bw4–, 
HLA-C1–, and HLA-C2–expressing K562 cells, K562 cells were trans-
fected with HLA-B*51:01, HLA-C*03:03, or HLA-C*05:02 cDNA, 
respectively, inserted into the expression vector pcDNA3.1 (Invitro-
gen, Groningen). Briefly, K562 cells were transfected by electropora-
tion with plasmid DNA (10 μg/1 × 106 cells) in Opti-MEM I with Glu-
tamax (Gibco, Thermo Fisher Scientific). Electroporation conditions 
were 250 V, 300 μF using the Gene Pulser II (Bio-Rad). Transfected 
cells were selected by the addition of G418 (1 mg/ml) to the culture 
medium and subsequently cloned by single-cell sorting of HLA+ cells 
using flow cytometry.
Degranulation assay. For the degranulation assay, splenic cell 
suspensions and nontransfected K562 or HLA-transfected K562 
cells were cocultured at a ratio of 10:1 for 5 hours with addition of 
monensin after 1 hour, and NK cells were then analyzed for expres-
sion of the degranulation marker CD107a. Single KIR+ NK cells were 
not pregated on NKG2A. Degranulation is presented as the differ-
ence between degranulation after K562 coculture and spontaneous 
degranulation (Δ%CD107a).
CD16 stimulation assay. For the degranulation assay, NUNC Mul-
tisorp plates were coated with 5 μg/ml anti-CD16 (clone 3G8, Bio-
Legend) overnight at 4°C. Thawed splenic cell suspensions were rest-
ed overnight in RPMI 1640 medium (Gibco BRL) supplemented with 
gentamicin (20 μg/ml) and 10% FCS (Gibco BRL) before being trans-
ferred onto coated plates for 6 hours with addition of monensin and 
brefeldin A after 1 hour. NK cells were then analyzed by flow cytom-
etry for expression of the degranulation marker CD107a. Degranula-
tion is presented as the difference between degranulation after CD16 
cross-linking and spontaneous degranulation (Δ%CD107a).
Quantification of EBV load by real-time PCR. Total DNA from 
whole blood was extracted using the NucliSENS EasyMAG System 
(bioMérieux) according to the manufacturer’s instructions. Splen-
ic tissue was processed using a QIAamp DNA Tissue Kit (QIAGEN) 
according to the manufacturer’s protocol. Quantitative analysis of 
EBV DNA was performed by the TaqMan (Applied Biosystems) real-
time PCR technique as previously described (57), with modified prim-
presence of side-by-side KIR ligand–mismatched donor recon-
stitution, mismatched EBV-transformed B cells might be more 
susceptible to NK cell lysis, while the response to their matched 
counterpart would still be dampened by KIR inhibition (40). 
Therefore, mixed HPC reconstitutions could be beneficial for con-
trolling herpesvirus infections, resulting in mixed, less-educated 
NK cell compartments that more efficiently control EBV infection, 
as shown in this study, and that might also possibly target CMV 
infection in humans.
Our study, therefore, contributes to an increasing body of liter-
ature that suggests that hematopoietic cell transplantation should 
be tailored to address the different therapeutic needs of patients. 
Completely HLA-matched transplantation reduces the risk for 
graft-versus-host disease, but haploidentical HLA-mismatched 
transplantation of T cell–depleted grafts mediates a potent GvL 
effect by NK cell alloreactivity. In addition, mixed transplantation 
of T cell–depleted grafts might alter NK cell education for more 
efficient herpesvirus-specific immune control. In support of this 
notion, our data suggest that even minor leukocyte populations 
lacking cognate HLA molecules for KIRs might reduce education 
of the respective KIR-carrying NK cell populations for improved 
EBV-specific immune control.
Methods
Mice. NOD/LtSz-scid IL2Rγnull (NOD-SCIDγc−/− or NSG) mice were 
obtained from The Jackson Laboratory and bred and maintained at 
the Institute of Experimental Immunology of the University of Zürich 
under specific pathogen–free conditions. Newborn NSG mice (1–5 
days old) were irradiated with 1 Gy using a Cs or x-ray source. Five to 
six hours after irradiation, mice were injected intrahepatically with 1 × 
105 to 2 × 105 CD34+ human HPCs derived from HFL tissue obtained 
from Advanced Bioscience Resources. Injected HPCs were either 
from a single donor or were a mix from 2 donors at a 1:1 ratio, amount-
ing to the same total cell numbers. Preparation of HFL tissue and iso-
lation of human CD34+ cells were performed as described previously 
(33, 34, 56). Reconstitution of human immune system components 
in mice (huNSG) was analyzed 10–12 weeks after engraftment and 
again just before the start of the experiments. Mice with more than 
40% reconstitution of huCD45+ human immune system components 
in the lymphocytes of peripheral blood were used in the described 
experiments (average 70% huCD45+ cells of peripheral blood lympho-
cytes, 25% CD3+ T cells of human lymphocytes, 60% CD19+ B cells of 
human lymphocytes, 5% NK cells of human lymphocytes, and 80% 
CD4+ and 20% CD8+ T cells of human T cells), were sex matched, and 
were 12–18 weeks old at the start of the experiments.
HLA typing. To perform HLA genomic typing, DNA was extracted 
using the QIAGEN GmbH reagent, according to the manufacturer’s 
instructions. HLA alleles were identified by a PCR sequence-specific 
oligonucleotide reverse assay using commercial HLA kits (Fujirebio 
Diagnostics Inc.). Data analysis was performed using LIPA Interpreta-
tion Software (Fujirebio Diagnostics Inc.).
Viral infection and NK cell depletion. GFP-EBV B95-8 WT was pro-
duced in 293 cells. Titration of viral concentrates was done on Raji 
cells in serial dilutions and calculated as Raji-infecting units (RIU) 
using flow cytometric analysis of GFP+ Raji cells 2 days after infection 
of cells. HuNSG mice were infected via i.p. injection of 1 × 105 RIU and 
followed for 5 weeks. Depletion of NK cells in huNSG mice was done 
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analyzed the data, and wrote the manuscript.
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